Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total G Dec 6, 2024 07:43PM
Janux Therapeutics (JANX) Prices 5.32M Share Offering at $63/sh Dec 5, 2024 06:05AM
Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants Dec 4, 2024 11:12PM
Janux Therapeutics (JANX) Announces Proposed $300M Share Offering Dec 3, 2024 04:02PM
Janux Therapeutics Announces Proposed Public Offering Dec 3, 2024 04:01PM


Dec 3, 2024 07:06AM William Blair on Janux Therapeutics (JANX): 'Exceeding Investor Expectations and Raising the Bar in mCRPC'
Feb 29, 2024 05:50AM Janux Therapeutics (JANX) Prices $296.5M Share and Warrant Offering at $46.50/sh
Feb 29, 2024 01:22AM Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Feb 27, 2024 05:00PM Janux Therapeutics (JANX) Announces Proposed $175M Share Offering
Feb 27, 2024 05:00PM Janux Therapeutics Announces Proposed Public Offering of Common Stock
Nov 14, 2022 09:18AM UPDATE: William Blair Starts Janux Therapeutics (JANX) at Outperform